位置:首页 > 蛋白库 > AL1A3_RAT
AL1A3_RAT
ID   AL1A3_RAT               Reviewed;         512 AA.
AC   Q8K4D8;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 118.
DE   RecName: Full=Aldehyde dehydrogenase family 1 member A3;
DE            EC=1.2.1.36 {ECO:0000250|UniProtKB:P47895};
DE   AltName: Full=Aldehyde dehydrogenase 6;
DE   AltName: Full=Retinaldehyde dehydrogenase 3;
DE            Short=RALDH-3;
DE            Short=RalDH3;
GN   Name=Aldh1a3; Synonyms=Aldh6, Raldh3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=12390888; DOI=10.1095/biolreprod.102.007021;
RA   Rexer B.N., Ong D.E.;
RT   "A novel short-chain alcohol dehydrogenase from rats with retinol
RT   dehydrogenase activity, cyclically expressed in uterine epithelium.";
RL   Biol. Reprod. 67:1555-1564(2002).
CC   -!- FUNCTION: NAD-dependent aldehyde dehydrogenase that catalyzes the
CC       formation of retinoic acid (By similarity). Has high activity with all-
CC       trans retinal, and has much lower in vitro activity with acetaldehyde
CC       (By similarity). Required for the biosynthesis of normal levels of
CC       retinoic acid in the embryonic ocular and nasal regions; retinoic acid
CC       is required for normal embryonic development of the eye and the nasal
CC       region (By similarity). {ECO:0000250|UniProtKB:P47895,
CC       ECO:0000250|UniProtKB:Q9JHW9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=all-trans-retinal + H2O + NAD(+) = all-trans-retinoate + 2
CC         H(+) + NADH; Xref=Rhea:RHEA:42080, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17898, ChEBI:CHEBI:35291,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.2.1.36;
CC         Evidence={ECO:0000250|UniProtKB:P47895};
CC   -!- PATHWAY: Cofactor metabolism; retinol metabolism.
CC       {ECO:0000250|UniProtKB:P47895}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P47895}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9JHW9}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF434845; AAN03711.1; -; mRNA.
DR   RefSeq; NP_695212.1; NM_153300.1.
DR   AlphaFoldDB; Q8K4D8; -.
DR   SMR; Q8K4D8; -.
DR   STRING; 10116.ENSRNOP00000045261; -.
DR   jPOST; Q8K4D8; -.
DR   PaxDb; Q8K4D8; -.
DR   PRIDE; Q8K4D8; -.
DR   GeneID; 266603; -.
DR   KEGG; rno:266603; -.
DR   UCSC; RGD:628662; rat.
DR   CTD; 220; -.
DR   RGD; 628662; Aldh1a3.
DR   eggNOG; KOG2450; Eukaryota.
DR   InParanoid; Q8K4D8; -.
DR   OrthoDB; 153834at2759; -.
DR   PhylomeDB; Q8K4D8; -.
DR   BRENDA; 1.2.1.36; 5301.
DR   Reactome; R-RNO-5365859; RA biosynthesis pathway.
DR   UniPathway; UPA00912; -.
DR   PRO; PR:Q8K4D8; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; NAS:RGD.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD+) activity; ISO:RGD.
DR   GO; GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; IDA:RGD.
DR   GO; GO:0070403; F:NAD+ binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0070324; F:thyroid hormone binding; ISO:RGD.
DR   GO; GO:0031076; P:embryonic camera-type eye development; ISO:RGD.
DR   GO; GO:0048048; P:embryonic eye morphogenesis; ISO:RGD.
DR   GO; GO:0060324; P:face development; ISO:RGD.
DR   GO; GO:0070384; P:Harderian gland development; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0043584; P:nose development; ISO:RGD.
DR   GO; GO:0021768; P:nucleus accumbens development; ISO:RGD.
DR   GO; GO:0060166; P:olfactory pit development; ISO:RGD.
DR   GO; GO:0002072; P:optic cup morphogenesis involved in camera-type eye development; ISO:RGD.
DR   GO; GO:0021983; P:pituitary gland development; IEP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0042574; P:retinal metabolic process; ISO:RGD.
DR   GO; GO:0002138; P:retinoic acid biosynthetic process; IMP:RGD.
DR   GO; GO:0042573; P:retinoic acid metabolic process; ISO:RGD.
DR   GO; GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0060013; P:righting reflex; ISO:RGD.
DR   Gene3D; 3.40.309.10; -; 1.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Cytoplasm; Lipid metabolism; NAD; Oxidoreductase;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
FT   CHAIN           2..512
FT                   /note="Aldehyde dehydrogenase family 1 member A3"
FT                   /id="PRO_0000056480"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        280
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10008"
FT   ACT_SITE        314
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10008"
FT   BINDING         204
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
FT   BINDING         207
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
FT   BINDING         257..262
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
FT   BINDING         361
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
FT   BINDING         411
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
FT   SITE            181
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P47895"
SQ   SEQUENCE   512 AA;  56171 MW;  2A818D7472F67A5E CRC64;
     MATANGAVEN GQPDGKPPAL PRPIRNLEVK FTKIFINNDW HEPKSGRKFA TYNPSTLEKI
     CEVEEGDKPD VDKAVEAAQA AFQRGSPWRR LDALSRGQLL HQLADLIERD RAILATLETM
     DTGKPFLHAF FVDLEGCIKT FRYFAGWADK IQGRTIPTDD NVMCFTRHEP IGVCGAITPW
     NFPLLMLAWK LAPALCCGNT VVLKPAEQTP LTALYLASLI KEVGFPPGVV NIVPGFGPTV
     GAAISSHPQI NKIAFTGSTE VGKLVKEAAS RSNLKRVTLE LGGRNPCIVC ADADLDLAVE
     CAHQGVFFNQ GQCCTAASRV FVEEQVYGEF VRRSVEFAKK RPVGDPFDAK TEQGPQIDQK
     QFDKILELIE SGKKEGAKLE CGGSAMEDRG LFIKPTVFSD VTDNMRIAKE EIFGPVQPIL
     KFKNLEEVIK RANSTDYGLT AAVFTKNLDK ALKLASALES GTVWVNCYNA FYAQAPFGGF
     KMSGNGRELG EYALAEYTEV KTVTIKLDEK NP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024